Jazz Pharmaceuticals plc — Director's Dealing 2019

Feb 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-02-25

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-25	Ordinary Shares	F	783	$126.25	Disposed	40401	Direct
2019-02-26	Ordinary Shares	F	663	$127.76	Disposed	39738	Direct
2019-02-27	Ordinary Shares	M	6666	$46.83	Acquired	46404	Direct
2019-02-27	Ordinary Shares	S	6666	$140.0	Disposed	39738	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-27	Non-Qualified Stock Option (right to buy)	$46.83	M	6666	Disposed	2022-08-08	Ordinary Shares (6666)	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This non-qualified stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.